All Mallinckrodt Pharmaceuticals articles

  • Pharmaceuticals
    Article

    DOJ intervenes in whistleblower suit against Mallinckrodt

    2020-03-04T17:56:00Z

    The Department of Justice has intervened in a whistleblower lawsuit against Mallinckrodt over allegations the drug maker knowingly underpaid Medicaid rebates it owed due to significant price increases to its drug Acthar.

  • oxy_450x200_-_homepage
    Article

    The compliance side of the war on drugs

    2017-07-21T13:45:00Z

    In a precedent-setting case, drugmaker Mallinckrodt Pharmaceuticals has agreed to a $35 million settlement with the U.S. federal government for failing to monitor its sales channels for suspicious orders.